SCHRODINGER INC
SDGRNASDAQTrading Snapshot
- Day Range
- $26.80 – $31.07
- 52-Week Range
- $10.95 – $33.78
- Volume (shares)
- 3,310,798
- Avg Volume (shares)
- —
- Shares Outstanding
- 74.8M
- Next Earnings
- 2026-11-04
Fundamentals Snapshot
- Annual Revenue
- $256M
- Last Q Revenue
- $59M
- P/E Ratio
- -36.1
- P/S Ratio
- 7.7x
- EPS (TTM)
- $-0.73
- Dividend Yield
- 0.00%
- Dilution (1yr)
- +1.1%
SCHRODINGER INC
SDGR
StockOtter · stockotter.spaceAbout SCHRODINGER INC
Schrödinger, Inc., together with its subsidiaries, develops physics-based computational platform that enables discovery of novel molecules for drug development and materials applications in the United States, the Asia-Pacific, Europe, Middle East, Africa, and internationally. The company operates in two segments, Software and Drug Discovery. The Software segment sells its software to transform molecular discovery for life sciences and materials science industries. The Drug Discovery segment focuses on building a portfolio of preclinical and clinical programs, internally and through collaborations. It has a research collaboration and license agreement with Novartis Pharma AG to advance multiple development candidates. Schrödinger, Inc. was incorporated in 1990 and is based in New York, New York.
Otter Score Breakdown
How it's scoredFive components, each rated 1–5★ and equally weighted (20%), averaged to a 0–100 score:💎 Quality — gross margin🚀 Growth — revenue YoY⚖️ Valuation — P/S ratio⚡ Momentum — 30-day price change💧 Dilution — 1-yr share issuance (buybacks score higher)Analyst Ratings
ⓘLatest News & Updates
Earnings Preview: Schrodinger, Inc. (SDGR) Q3 Earnings Expected to Decline
Schrodinger (SDGR) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Schrödinger to Present at UBS Global Healthcare Conference
NEW YORK--(BUSINESS WIRE)--Schrödinger, Inc. (Nasdaq: SDGR) today announced that management will participate in a fireside chat at the UBS Global Healthcare Conference. The live presentation will take place on Tuesday, N
Schrödinger Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
NEW YORK--(BUSINESS WIRE)--Schrödinger, Inc. (Nasdaq: SDGR) today reported that on October 21, 2026, the company granted restricted stock units (RSUs) with respect to 5,716 shares of the company's common stock to five ne
Schrodinger, Inc. $SDGR Shares Newly Purchased by Counterpoint Mutual Funds LLC
Counterpoint Mutual Funds LLC purchased a new stake in shares of Schrodinger, Inc. (NASDAQ: SDGR) in the third quarter, according to its most recent filing with the Securities and Exchange Commission. The firm purchased
Schrödinger Research Published in Nature Reveals New Insights into Lithium-Ion Battery Chemistry
NEW YORK--(BUSINESS WIRE)---- $SDGR #AI--Schrödinger, Inc. (Nasdaq: SDGR) today announced the publication of new research in Nature that reveals critical insights into the atomic-scale structure of lithium-ion battery (L
Reviewing Claritev (NYSE:CTEV) and Schrodinger (NASDAQ:SDGR)
Schrodinger (NASDAQ: SDGR - Get Free Report) and Claritev (NYSE: CTEV - Get Free Report) are both healthcare companies, but which is the better investment? We will contrast the two companies based on the strength of thei